Daniel J. Haraf

Daniel Haraf practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Daniel Haraf's NPI, 1356400899, was assigned on December 8, 2006. Daniel Haraf graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1982. Daniel Haraf holds Illinois license 036067736.

Daniel Haraf's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Daniel Haraf's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Daniel Haraf is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians (University of Chicago Physicians Group). Dmand AI also links Daniel Haraf to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Haraf practices. Vendor and product names are available with a free account.

Radiation oncology is Daniel Haraf's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Daniel Haraf is board certified in internal medicine by the American Board of Internal Medicine. Daniel Haraf is licensed in Illinois.

Dmand AI lists head & neck cancer radiation among the conditions Daniel Haraf treats.

CMS data shows 203 Medicare services from Daniel Haraf across 3 procedure codes in 2024, for 106 Medicare patients. Medicare paid $8,223 for them.

CMS counts 106 Medicare patients who saw Daniel Haraf in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Haraf's median patient age at 68, with 39% women.

In 2021, Daniel Haraf wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $37 in total drug cost.

Daniel Haraf accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 101 papers to Daniel Haraf, published from 2008 to 2025. 2011 was the busiest year, with 6. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Head and Neck Neoplasms and Fluorouracil. Daniel Haraf has published most often in J Clin Oncol. Daniel Haraf's most frequent co-authors are Ezra E. Cohen, MD, Bruce Earl Brockstein, MD and Philip C. Hoffman.

Dmand AI links Daniel Haraf to 1 clinical trial. Conditions studied include Oropharyngeal Neoplasms and Pharyngeal Neoplasms.

CMS Open Payments shows 5 general payments to Daniel Haraf from 2 drug and device companies from 2016 to 2018. Consulting fees make up the largest share, 94% of the total. Merck Sharp & Dohme Corporation paid the most, $3,786.

Dmand AI lists 5 awards for Daniel Haraf, most recently America's Top Doctors in 2014.

Daniel Haraf graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1982.

Daniel Haraf is in network with 10 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.